Disease
8 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 5, 2026 · JOURNAL ARTICLE
Immunotherapy
This is a narrative review that raises questions and summarizes progress rather than reporting empirical results with effect sizes or comparative outcomes to answer them.
AUG 30, 2026 · JOURNAL ARTICLE
Vaccines
Expert consensus position paper synthesizing evidence on chikungunya epidemiology, clinical features, diagnostics, and prevention strategies to inform public health policy and immunization strategy in Mexico.
AUG 16, 2026 · JOURNAL ARTICLE
International Journal for Multidisciplinary Research
A single-centre cross-sectional study with confirmed dengue cases and RT-PCR serotyping showing associations between DENV-2 and disease severity, supported by hematological markers, but lacking prospective design and external validation.
AUG 16, 2026 · JOURNAL ARTICLE
Advances in Clinical Medical Research
A cross-sectional molecular epidemiology study with confirmed RT-PCR diagnosis linking DENV-2 predominance to severe dengue via multivariate logistic regression, but limited by single-centre design and modest sample size of confirmed cases.
AUG 16, 2026 · JOURNAL ARTICLE
Advances in Clinical Medical Research
A single-centre cross-sectional molecular epidemiology study identifying DENV-2 as predominant and associated with severe dengue (OR 2.91, p=0.009), with clear serotype distribution and clinical correlates, but limited by observational design and modest sample size.
AUG 11, 2026 · JOURNAL ARTICLE
Clinical Neurology and Neuroscience
This is a clinical review of a rare disease with uncertain etiology; it synthesizes existing knowledge rather than presenting new experimental evidence, and the source explicitly states the causal mechanism remains debated and uncertain.
AUG 10, 2026 · JOURNAL ARTICLE
World Advances in Renal Medicine
A narrative review synthesizing molecular mechanisms and treatment strategies in RCC, offering expert perspective on current and emerging approaches rather than reporting original research findings.
JUL 28, 2026 · JOURNAL ARTICLE
The Journal of Immunology
Phase 1 open-label human challenge study in a small, dengue-naïve cohort characterizing immune mechanistic endpoints (non-neutralizing antibody functions) without a comparator or clinical outcome measure.